🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Treatment Acquiring Traction Online

The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with thousands of members share comparison images, injection guides and claims of next-day British shipping. Vendors market the substance there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and chemists have warned that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could result in users administering substances of uncertain source.

Several experts said the popularity for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Material Elimination

According to TikTok, the platform has taken down problematic material and prohibited associated hashtags and search suggestions. The company said it was committed to maintaining the platform safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays groups with numerous of users, filled with photos of slimming results, positive reviews and step-by-step instructions for preparing or administering at home.

Within moments of joining one group, a seller posted contact information, where the majority of transactions take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, health issues or past usage.

Product Details and Costs

Within these communities, messages show dark colored packages with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a injector should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram said it actively monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering materials they cannot confirm. Although the science behind this drug is sound, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her staff has previously encountered individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose patients to possibly serious health risks”.